Series C - Endogenex
Investment Firm
Overview
Endogenex develops an endoscopic procedure to help patients with type 2 diabetes regain control of their blood glucose levels.
Announced Date
Jun 25, 2024
Closed on Date
Jun 25, 2024
Funding Type
Series C
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
6
Round Details and Background
Endogenex raised $88000000 on 2024-06-25 in Series C
Endogenex develops an endoscopic procedure to help patients with type 2 diabetes regain control of their blood glucose levels.
Company Funding History
6
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Dec 05, 2018 |  Venture Round - Endogenex | - | 12.8M | |
| Feb 13, 2018 | Pre Seed Round - Endogenex | - | 140.0K | |
| Apr 20, 2021 | Venture Round - Endogenex | 1 | - | 12.0M |
| Jun 25, 2024 | Series C - Endogenex | 7 | - | 88.0M |
Recent Activity
There is no recent news or activity for this profile.